Akums Drugs' first indigenous Hydroxyurea oral solution for Sickle Cell Disease comes for ₹600 only and is stable at room temperature.
Hydroxyurea oral solution- a medication used to treat Sickle Cell Disease (Supplied)
Indian pharmaceutical company Akums Drugs and Pharmaceuticals has launched the country’s first indigenous Hydroxyurea oral solution to treat sickle cell disease. Remarkably, it will cost merely one percent of the price of global brands of approximately ₹77,000. The Hydroxyurea oral solution reduces the number of painful crises the condition causes and decreases the need for blood transfusions.